Michael Heffernan

Michael Heffernan is recorded as Chairman at Avalo Therapeutics, Inc. (AVTX) since March 25, 2025 and Board Member at Avalo Therapeutics, Inc. (AVTX) since January 1, 2025. The newest filing on record that lists Michael Heffernan as Board Member at Avalo Therapeutics, Inc. (AVTX) is dated April 10, 2026. Avalo Therapeutics, Inc. reported in an 8-K filed June 8, 2026 that Michael Heffernan was appointed Director, effective June 2, 2026. Avalo Therapeutics, Inc. reported in an 8-K filed March 26, 2025 that Michael Heffernan was appointed Chairman of the Board, effective March 25, 2025. Avalo Therapeutics, Inc. reported in an 8-K filed March 26, 2025 that Michael Heffernan was appointed Board, effective March 25, 2025. Avalo Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Avalo Therapeutics, Inc. includes Garry A. Neil (CEO), Garry Neil (CEO and Board Member), Michael Cola (CEO, Chairman and Board Member) and 7 others.